Search Results - "Humaidan, P."

'I Don't Feel I'm Capable of More': Affect, Literacy, Dis/Ability

Authors: Bacon, Heidi R. Rolim, Paula Humaidan, Abdulsamad

Source: Journal of Literacy Research. Mar 2022 54(1):51-73.

Peer Reviewed: Y

Page Count: 23

Descriptors: Literacy, Students with Disabilities, Student Experience, Self Concept, Psychological Patterns, Labeling (of Persons), Social Bias, Adult Students

Evaluating safety and Influence of early Luteal Phase withdrawal at 8 weeks instead of 12 weeks on pregnancy continuation after ART.

Authors: Gurnani, D. Humaidan, P. Aggarwal, S. et al.

Source: Human Reproduction. 2026 Supplement, Vol. 41, pi711-i711. 2/3p.

Early pregnancy bleeding after assisted reproductive technology: a systematic review and secondary data analysis from 320 patients undergoing hormone replacement therapy frozen embryo transfer.

Authors: Nielsen, J M Humaidan, P Jensen, M B et al.

Source: Human Reproduction. Dec2023, Vol. 38 Issue 12, p2373-2381. 9p.

Luteal phase rescue in high-risk OHSS patients by GnRHa triggering in combination with low-dose HCG: a pilot study.

Authors: Humaidan, P.¹ peter.humaidan@sygehusviborg.dk

Source: Reproductive BioMedicine Online (Reproductive Healthcare Limited). May2009, Vol. 18 Issue 5, p630-634. 5p.

Rescue of corpus luteum function with periovulatory HCG supplementation in IVF/ICSI GnRH antagonist cycles in which ovulation was triggered with a GnRH agonist: a pilot study.

Authors: Humaidan, P. Bungum, L. Bungum, M. et al.

Source: Reproductive BioMedicine Online (Reproductive Healthcare Limited). Aug2006, Vol. 13 Issue 2, p173-178. 6p.

Reproductive outcome using a GnRH antagonist (cetrorelix) for luteolysis and follicular synchronization in poor responder IVF/ICSI patients treated with a flexible GnRH antagonist protocol.

Authors: Humaidan, P. Bungum, L. Bungum, M. et al.

Source: Reproductive BioMedicine Online (Reproductive Healthcare Limited). Dec2005, Vol. 11 Issue 6, p679-684. 6p.

The devil lies in the detail—the role of intensive exogenous progesterone supplementation in the endometriosis patient undergoing HRT-FET.

Authors: Humaidan, P Alsbjerg, B

Source: Human Reproduction. Nov2024, Vol. 39 Issue 11, p2630-2631. 2p.

What to expect from a 'standard vaginal progesterone regimen' in hormone replacement therapy frozen embryo transfer (HRT-FET) – a PRISMA review and meta-analysis.

Authors: Alsbjerg, B. Humaidan, P.

Source: Reproductive BioMedicine Online (Elsevier Science). May2025, Vol. 50 Issue 5, pN.PAG-N.PAG. 1p.

Efficacy and safety of follitropin alfa/lutropin alfa in ART: a randomized controlled trial in poor ovarian responders.

Authors: Humaidan, P. Chin, W. Rogoff, D. et al.

Source: Human Reproduction. Mar2017, Vol. 32 Issue 3, p544-555. 12p. 1 Diagram, 9 Charts.

Ovarian hyperstimulation syndrome: review and new classification criteria for reporting in clinical trials.

Authors: Humaidan, P. Nelson, S. M. Devroey, P. et al.

Source: Human Reproduction. Sep2016, Vol. 31 Issue 9, p1997-2004. 8p. 1 Diagram, 1 Chart.

Luteinizing Hormone Dynamic is similar in patients with optimal and suboptimal response in normal reserve patients during ovarian stimulation.

Authors: Bozdag, G. Boynukalin, F. K. Humaidan, P. et al.

Source: Human Reproduction. 2026 Supplement, Vol. 41, pi618-i619. 2p.

GnRHa trigger and individualized luteal phase hCG support according to ovarian response to stimulation: two prospective randomized controlled multi-centre studies in IVF patients.

Authors: Humaidan, P. Polyzos, N.P. Alsbjerg, B. et al.

Source: Human Reproduction. Sep2013, Vol. 28 Issue 9, p2511-2521. 11p. 1 Diagram, 4 Charts.

Endometrial gene expression in the early luteal phase is impacted by mode of triggering final oocyte maturation in recFSH stimulated and GnRH antagonist co-treated IVF cycles.

Authors: Humaidan, P. Van Vaerenbergh, I. Bourgain, C. et al.

Source: Human Reproduction. Nov2012, Vol. 27 Issue 11, p3259-3272. 14p.

GnRH agonist for triggering of final oocyte maturation: time for a change of practice?

Authors: Humaidan P Kol S Papanikolaou E et al.

Source: Human Reproduction Update. Jul2011, Vol. 17 Issue 4, p510-524. 15p.

GnRHa to trigger final oocyte maturation: a time to reconsider.

Authors: Humaidan, P. Papanikolaou, E. G. Tarlatzis, B. C.

Source: Human Reproduction. Oct2009, Vol. 24 Issue 10, p2389-2394. 6p. 3 Charts.

Recombinant LH supplementation to recombinant FSH during the final days of controlled ovarian stimulation for in vitro fertilization. A multicentre, prospective, randomized, controlled trial.

Authors: NyboeAndersen, A Humaidan, P Fried, G et al.

Source: Human Reproduction. Feb2008, Vol. 23 Issue 2, p427-434. 8p.

THE ROLE OF ENDOGENOUS AND EXOGENOUS LH IN ART.

Authors: Humaidan, P.¹ (AUTHOR)

Source: Reproductive BioMedicine Online (Reproductive Healthcare Limited). Nov2010 Supplement 1, Vol. 21 Issue S1, pS8-S9. 2p.

This result is not displayed to guests.
Login for full access.

Should Cochrane reviews be performed during the development of new concepts?

Authors: Humaidan P Kol S Engmann L et al.

Source: Human Reproduction. Jan2012, Vol. 27 Issue 1, p6-8. 3p.

Non-transparent and insufficient descriptions of non-validated microbiome methods and related reproductive outcome results should be interpreted with caution.

Authors: Haahr, T Humaidan, P Jensen, J S

Source: Human Reproduction. Oct2019, Vol. 34 Issue 10, p2083-2084. 2p.